The AMR Action Fund is a groundbreaking VC fund that enables breakthroughs in the development of antibiotics, anti-fungals, and other antimicrobials. We invest in companies developing innovative treatments for priority drug-resistant pathogens and advocate for market reforms and policy solutions to change how society values these lifesaving drugs.
| Website | http://amractionfund.com |
| Employees | 28 (17 on RocketReach) |
| Founded | 2020 |
| Technologies |
JavaScript
,
HTML
,
Twitter
+18 more
(view full list)
|
| Industry | Venture Capital and Private Equity Principals |
| Keywords | Drug Resistance, Antimicrobial Resistance, Infectious Disease, Microbial Therapeutics, Pharmaceutical Investment, Drug Discovery, Venture Capital, New Antibiotics, Innovative Treatments, Global Health |
| Competitors | Biogen, Calico Life Sciences, NanoString Technologies, Inc., Senti Biosciences, Twentyeight Health, Elysium Health, UNITY Biotechnology, Rejuvenate Bio, Elevian, Inc., Aging.com +23 more (view full list) |
Looking for a particular AMR Action Fund employee's phone or email?
Henry Skinner is the CEO of AMR Action Fund.
17 people are employed at AMR Action Fund.